| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |